Early Biomarker Kidney Injury Assessment After Acumen Directed Fluid Management in Cardiac Surgery

Starting soon · Not applicable

Conditions studied: Renal Injury, Acute Kidney Injury

In brief

This study is to assess the benefits of goal-directed fluid management with ACUMEN in cardiac surgical patients and its impact on cardiac surgery-induced kidney injury.

Key facts

Study ID

NCT06109714

Run by

University of Maryland, Baltimore

People needed

100

Starts

2026-09-01

Expected to finish

2030-12-31

Last updated by the study team

2026-06-23

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult patients undergoing cardiopulmonary bypass
• Procedure coronary artery bypass grafting, aortic valve replacement, or both

You may not qualify if…

• Patients < 18 years old
• Emergent surgery
• Preoperative kidney disease (Cr > 2.0 or on renal replacement therapy)
• Ejection fraction < 40%
• Incomplete data in medical record

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.